Medarex's Landmark Deal With BMS: 'What We Set Out To Do'
By Randall Osborne
Monday, November 15, 2004
Industry leaders like to use phrases such as "going forward" and "as the company evolves," even though a troubling number of firms in biotechnology (and other industries) tend instead to stall, slide or die.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.